Vericel
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vericel and other ETFs, options, and stocks.About VCEL
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel.
VCEL Key Statistics
Stock Snapshot
With a market cap of 1.89B, Vericel(VCEL) trades at $37.40. The stock has a price-to-earnings ratio of 160.17.
As of 2026-01-16, Vericel(VCEL) stock has fluctuated between $37.36 and $39.07. The current price stands at $37.40, placing the stock +0.1% above today's low and -4.3% off the high.
The Vericel(VCEL)'s current trading volume is 397.84K, compared to an average daily volume of 635.88K.
During the past year, Vericel(VCEL) stock moved between $29.24 at its lowest and $63.00 at its peak.
During the past year, Vericel(VCEL) stock moved between $29.24 at its lowest and $63.00 at its peak.
VCEL News
As of January 2026, the U.S. stock market has shown a mixed performance with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average ending low...
Advertisement Why Vericel’s latest guidance is drawing fresh attention Vericel (VCEL) has put out preliminary, unaudited guidance pointing to 23% revenue grow...
Vericel Corporation recently issued preliminary, unaudited guidance for the fourth quarter and full year 2025, pointing to 23% quarterly revenue and MACI sales...
Analyst ratings
88%
of 8 ratingsMore VCEL News
“The Company executed extremely well in 2025, delivering strong revenue and profitability growth,” said Nick Colangelo, President and CEO of Vericel (VCEL). “We...